EG 427 announces that Dr. Greg Sarek, VP Research will be presenting at the 3rd annual Next Generation Gene Therapy Vectors conferenceJune 20, 2023
Dr. Greg Sarek, VP Research, will be presenting the company’s unique non-replicative HSV-1 vector platform during the 3rd annual Next Generation Gene Therapy Vectors.
Focusing on ways to identify and adapt novel gene therapy vector properties to progress safer, targeted and efficacious therapies, the conference will host Dr. Greg Sarek to give an in-person presentation on Tuesday, June 27 , at 3:10 pm ET at the conference venue in Boston. His talk will elaborate on the power of non-replicative HSV-1 gene delivery platform to address local chronic neuronal disorders.
Read full press release here